glp-1 and parkinson's A new Science Perspective highlights the growing body of evidence that hints at the potential of GLP-1–based medications in treating conditions other than diabetes obesity, including cardiovascular disease and neurodegenerative disorders GLP-1 Signalling as a Therapeutic

Beginners should start with 300 mcg daily via subcutaneous injection, administered in the morning fasted state

Dosing NAC at 6001200mg daily increases hepatic glutathione production by supplying cysteine without the bioavailability constraints of intact glutathione

Found in fresh vegetables and fruit, antioxidants may help reduce tissue damage from inflammation

According to a recent review of pre-clinical and clinical studies, GLP-1 receptors have been identified in testicular tissue, including Leydig cells (which produce testosterone), Sertoli cells (which help support sperm development), and even sperm cells themselves